All entries for: Filana Therapeutics

March 12, 2026

Filana Therapeutics

Negative Outlook

Austin, TX
1-50 employees

We do not and cannot understand or anticipate the full impact and potential implications of the IRA on our business or on our drugs, however, we currently believe the IRA may reduce the prices we are able to obtain for our product candidates, if approved in the United States.

Disease Area: Neurological Diseases, Rare Diseases
Drug Type: Small Molecule
Scroll to Top